IndraLab

Statements

USP13 activates 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexenyl]methyl]-1-piperazinyl]-N-[4-[[(2R)-4-(4-morpholinyl)-1-(phenylthio)butan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide. 2 / 2

| 2

➶

reach

"Conversely, USP13 overexpression in NCI-H2170 cells modestly impaired the inhibitory effects of ABT-263."

29335437

➶

reach

"As anticipated, USP13 knockdown by siRNAs or knockout by CRISPR and Cas9 increased sensitivity to ABT-263 in SW-1573 and TOV-21G cells."

29335437

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP13 activates 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexenyl]methyl]-1-piperazinyl]-N-[4-[[(2R)-4-(4-morpholinyl)-1-(phenylthio)butan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide. 2 / 2

INDRA sources:

Databases

Reading